Bioavailability and Pharmacokinetics of Mango

NCT03365739 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2020-07-14

No results posted yet for this study

Summary

The primary objectives of the study are:

1. To investigate the relative bioavailability and absorption/kinetic profile of phytochemicals after acute consumption of mango pulp.
2. To study the systemic accumulation or generation of new mango pulp phytochemicals /their metabolites in blood after regular mango intake for an extended time frame.
3. To enhance the bioavailability of polyphenols in mango pulp by addition of Vitamin C to the mango pulp.

Conditions

  • Healthy Subjects

Interventions

DIETARY_SUPPLEMENT

Active Comparator 1

Mango (pulp/flesh) (500 g)

DIETARY_SUPPLEMENT

Active Comparator 2

Mango (500 g) + Vitamin C (100 mg)

DIETARY_SUPPLEMENT

Control Comparator

Vitamin C (100 mg)

Sponsors & Collaborators

  • Clinical Nutrition Research Center, Illinois Institute of Technology

    lead INDUSTRY

Principal Investigators

  • Britt Burton-Freeman, Ph.D · Illinois Institute of Technology

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-17
Primary Completion
2019-05-22
Completion
2020-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03365739 on ClinicalTrials.gov